1 2 3 >  Last ›
December 4, 2018
American CryoStem Receives Final Patent to Complete its Core Cellular Platform
EATONTOWN, NJ / ACCESSWIRE / December 4 , 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular products and technologies for the Regenerative and Personalized Medicine industries, today announced receipt from the USPTO of the Issue Notification for our Patent titled ''Systems and Methods for the Digestion of Adipose Tissue Samples from a Client for Cryopreservation'' for Application No. 13/646,647 (the ''Digestion Patent'') which will be formally issued on December 18, 2018.
August 21, 2018
American CryoStem Announces Receipt of Key Business Method Patent for its Cellular Platform
EATONTOWN, NJ / ACCESSWIRE / August 21, 2018 /American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced receipt of Patent No. US 10,014,079 B2 "Business Method for Collecting, Processing, Cryogenic Storage, and Distribution of a Biologic Sample Material"from the U.S. Patent and Trademark Office (USPTO) for U.S. patent application 13/702.304 covering the Company's methods of Collection, Processing, Cryogenic Storage and Distribution of adipose tissue and adipose derived stem cells.
July 12, 2018
American CryoStem Announces Launch of ATGRAFT(TM) in China
EATONTOWN, NJ / ACCESSWIRE / July 12, 2018 / American CryoStem Corporation (OTC PINK: CRYO), a leading strategic application developer, marketer, and global licensor of patented adipose tissue-based cellular technologies, for the Regenerative and Personalized Medicine industries, today announced the national launch of CRYO's ATGRAFTTM tissue collection, processing and storage technology by Baoxin Asia Pacific Biotechnology (Shenzhen) Co. Ltd. ("Baoxin") in China. John Arnone, CEO and Anthony Dudzinski, COO, of CRYO traveled throughout south east China with the management and marketing team of Baoxin to present the ATGRAFTTM platform to leading plastic and cosmetic surgery hospitals in Shenzhen, Nanning, Guangzhou, Guangxi and Changsha. Additionally, Mr. Arnone and Mr. Dudzinski, attended the signing of investment documents between Baoxin and Chinese government and Banking officials in Shenzhen, China as well as the official launch presentation and evening gala hosted by Baoxin in Shenzhen. Baoxin is being financed by a combination of China's CITIC Group and the China Development Bank.
June 19, 2018
American CryoStem to Develop Standardized Tissue Scoring System
EATONTOWN, NJ / ACCESSWIRE / June 19, 2018 / American CryoStem Corporation (OTC PINK: CRYO), a leading strategic application developer, marketer, global licensor of patented adipose tissue-based cellular technologies, for the Regenerative and Personalized Medicine industries, today announced a new scientific project to create a Histological Scoring System for Collected Lipoaspirate. This project is based upon the Company's extensive experience with its ATGRAFT™ product and requests from the physician community to provide additional data related to the results of different tissue harvesting techniques, processing, storage and post-storage tissue and cell viability. The Company's Chief Scientific Officer, Michael Moeller, Ph.D., will be performing the study with the assistance of the Histology Core at Rutgers University in New Jersey.
April 26, 2018
American CryoStem to Exhibit at The Aesthetic Meeting 2018 in New York, NY
About American CryoStem Corporation
April 5, 2018
American CryoStem Enters Into Agreement to License its Patented Adipose Tissue and Stem Cell Technologies in Thailand
March 27, 2018
Cryo Announces Notice of Allowance of Claims for Its Core Patent
EATONTOWN, NJ / ACCESSWIRE / March 27, 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced receiving a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for U.S. patent application 13/702.304 related to methods of Collection, Processing, Cryogenic Storage and Distribution of a Biologic Sample.
January 16, 2018
American Cryostem Corporation 2017 Year End Update
EATONTOWN, NJ / ACCESSWIRE / January 16, 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today released Summary corporate and financial highlight information regarding the Company's Year ending September 30, 2017;
 1 2 3 >  Last ›